Cargando…

Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study

BACKGROUND: Selective Decontamination of the Digestive tract (SDD) aims to prevent nosocomial infections, by eradication of potentially pathogenic micro-organisms from the digestive tract. OBJECTIVES: To estimate the rate of and the time to eradication of resistant vs. susceptible facultative aerobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Buitinck, Sophie H., Jansen, Rogier, Bosman, Rob J., van der Meer, Nardo J. M., van der Voort, Peter H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853443/
https://www.ncbi.nlm.nih.gov/pubmed/35185812
http://dx.doi.org/10.3389/fmicb.2021.779805
_version_ 1784653228897468416
author Buitinck, Sophie H.
Jansen, Rogier
Bosman, Rob J.
van der Meer, Nardo J. M.
van der Voort, Peter H. J.
author_facet Buitinck, Sophie H.
Jansen, Rogier
Bosman, Rob J.
van der Meer, Nardo J. M.
van der Voort, Peter H. J.
author_sort Buitinck, Sophie H.
collection PubMed
description BACKGROUND: Selective Decontamination of the Digestive tract (SDD) aims to prevent nosocomial infections, by eradication of potentially pathogenic micro-organisms from the digestive tract. OBJECTIVES: To estimate the rate of and the time to eradication of resistant vs. susceptible facultative aerobic gram-negative bacteria (AGNB) in patients treated with SDD. METHODS: This observational and retrospective study included patients admitted to the ICU between January 2001 and August 2017. Patients were included when treated with SDD (tobramycin, polymyxin B, and amphotericin B) and colonized in the upper or lower gastro-intestinal (GI) tract with at least one AGNB present on admission. Decontamination was determined after the first negative set of cultures (rectal and throat). An additional analysis was performed of two consecutive negative cultures. RESULTS: Of the 281 susceptible AGNB in the throat and 1,087 in the rectum on admission, 97.9 and 93.7%, respectively, of these microorganisms were successfully eradicated. In the upper GI-tract no differences in eradication rates were found between susceptible and resistant microorganisms. However, the median duration until eradication was significantly longer for aminoglycosides resistant vs. susceptible microorganisms (5 vs. 4 days, p < 0.01). In the lower GI-tract, differences in eradication rates between susceptible and resistant microorganisms were found for cephalosporins (90.0 vs. 95.6%), aminoglycosides (84.4 vs. 95.5%) and ciprofloxacin (90.0 vs. 95.2%). Differences in median duration until eradication between susceptible and resistant microorganisms were found for aminoglycosides and ciprofloxacin (both 5 days vs. 6 days, p = 0.001). Decontamination defined as two negative cultures was achieved in a lower rate (77–98% for the upper GI tract and 64–77% for the lower GI tract) and a median of 1 day later. CONCLUSION: The vast majority of both susceptible and resistant microorganisms are effectively eradicated from the upper and lower GI tract. In the lower GI tract decontamination rates of susceptible microorganisms are significantly higher and achieved in a shorter time period compared to resistant strains.
format Online
Article
Text
id pubmed-8853443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88534432022-02-18 Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study Buitinck, Sophie H. Jansen, Rogier Bosman, Rob J. van der Meer, Nardo J. M. van der Voort, Peter H. J. Front Microbiol Microbiology BACKGROUND: Selective Decontamination of the Digestive tract (SDD) aims to prevent nosocomial infections, by eradication of potentially pathogenic micro-organisms from the digestive tract. OBJECTIVES: To estimate the rate of and the time to eradication of resistant vs. susceptible facultative aerobic gram-negative bacteria (AGNB) in patients treated with SDD. METHODS: This observational and retrospective study included patients admitted to the ICU between January 2001 and August 2017. Patients were included when treated with SDD (tobramycin, polymyxin B, and amphotericin B) and colonized in the upper or lower gastro-intestinal (GI) tract with at least one AGNB present on admission. Decontamination was determined after the first negative set of cultures (rectal and throat). An additional analysis was performed of two consecutive negative cultures. RESULTS: Of the 281 susceptible AGNB in the throat and 1,087 in the rectum on admission, 97.9 and 93.7%, respectively, of these microorganisms were successfully eradicated. In the upper GI-tract no differences in eradication rates were found between susceptible and resistant microorganisms. However, the median duration until eradication was significantly longer for aminoglycosides resistant vs. susceptible microorganisms (5 vs. 4 days, p < 0.01). In the lower GI-tract, differences in eradication rates between susceptible and resistant microorganisms were found for cephalosporins (90.0 vs. 95.6%), aminoglycosides (84.4 vs. 95.5%) and ciprofloxacin (90.0 vs. 95.2%). Differences in median duration until eradication between susceptible and resistant microorganisms were found for aminoglycosides and ciprofloxacin (both 5 days vs. 6 days, p = 0.001). Decontamination defined as two negative cultures was achieved in a lower rate (77–98% for the upper GI tract and 64–77% for the lower GI tract) and a median of 1 day later. CONCLUSION: The vast majority of both susceptible and resistant microorganisms are effectively eradicated from the upper and lower GI tract. In the lower GI tract decontamination rates of susceptible microorganisms are significantly higher and achieved in a shorter time period compared to resistant strains. Frontiers Media S.A. 2022-02-03 /pmc/articles/PMC8853443/ /pubmed/35185812 http://dx.doi.org/10.3389/fmicb.2021.779805 Text en Copyright © 2022 Buitinck, Jansen, Bosman, van der Meer and van der Voort. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Buitinck, Sophie H.
Jansen, Rogier
Bosman, Rob J.
van der Meer, Nardo J. M.
van der Voort, Peter H. J.
Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title_full Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title_fullStr Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title_full_unstemmed Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title_short Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
title_sort eradication of resistant and susceptible aerobic gram-negative bacteria from the digestive tract in critically ill patients; an observational cohort study
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853443/
https://www.ncbi.nlm.nih.gov/pubmed/35185812
http://dx.doi.org/10.3389/fmicb.2021.779805
work_keys_str_mv AT buitincksophieh eradicationofresistantandsusceptibleaerobicgramnegativebacteriafromthedigestivetractincriticallyillpatientsanobservationalcohortstudy
AT jansenrogier eradicationofresistantandsusceptibleaerobicgramnegativebacteriafromthedigestivetractincriticallyillpatientsanobservationalcohortstudy
AT bosmanrobj eradicationofresistantandsusceptibleaerobicgramnegativebacteriafromthedigestivetractincriticallyillpatientsanobservationalcohortstudy
AT vandermeernardojm eradicationofresistantandsusceptibleaerobicgramnegativebacteriafromthedigestivetractincriticallyillpatientsanobservationalcohortstudy
AT vandervoortpeterhj eradicationofresistantandsusceptibleaerobicgramnegativebacteriafromthedigestivetractincriticallyillpatientsanobservationalcohortstudy